CAP, Adenylate Cyclase-Associated Protein 1 (CAP1) (Middle Region) Peptide
Quick Overview for CAP, Adenylate Cyclase-Associated Protein 1 (CAP1) (Middle Region) Peptide (ABIN8096133)
Target
Source
Application
-
-
Protein Region
- Middle Region
-
Purpose
- CAP1 Peptide - middle region
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-CAP1 antibody ( ARP48296_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- CAP1 (CAP, Adenylate Cyclase-Associated Protein 1 (CAP1))
-
Background
-
Background Information: The protein encoded by this gene is related to the S. cerevisiae CAP protein, which is involved in the cyclic AMP pathway. The human protein is able to interact with other molecules of the same protein, as well as with CAP2 and actin. Alternatively splice
Alternative Symbols: CAP, CAP1-PEN
-
Molecular Weight
- 52kDa
-
Gene ID
- 10487
-
NCBI Accession
- NP_006358
-
UniProt
- Q01518
Target
-